SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, N…
- Recall date
- December 16, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0254-2026
- FDA classification
- Class II
- Brand / firm
- SpecGx, LLC
- Sold / distributed
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Get recall alerts
Free email alert whenever SpecGx, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SpecGx, LLC